Home › NDC Lookup › RxCUI directory › RxCUI 1041495

Bimatoprost 0.3 MG/ML Topical Solution — RxCUI 1041495

Name: Bimatoprost 0.3 MG/ML Topical Solution (RxCUI 1041495)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1041495 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1041495

Official nameBimatoprost 0.3 MG/ML Topical Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbimatoprost 0.03 % Eyelash Topical Solution

FDA products mapped3

Package NDCs mapped7

Reported Medicaid activity (SDUD)46 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bimatoprost Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Bimatoprost ophthalmic 0.03% is used to grow longer, thicker and darker eyelashes if you have hypotrichosis, meaning sparse lashes. Lumigan is a related bimatoprost eye drop used f...
Do it once at night on a clean face with makeup and contacts out. Put one drop on the sterile applicator and brush it along the upper lid at the base of the lashes. Blot extra, and...
No. Extra applications will not increase growth. If you stop, your lashes are expected to return to how they were before treatment.
Will using more make my lashes grow more?

📖 Read our full Bimatoprost Ophthalmic guide →

🕸️ Concept Web — How Bimatoprost 0.3 MG/ML Topical Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Bimatoprost 0.3 MG/ML Topical Solution RxCUI 1041495 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Bimatoprost 283810 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Latisse 831948 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bimatoprost Topical Solution 1041494 SCDF
- Bimatoprost Topical Product 1161199 SCDG
- Bimatoprost Topical Solution [Latisse] 1041496 SBDF
- Latisse Topical Product 1175655 SBDG
- Topical Solution 316986 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Bimatoprost 0.3 MG/ML 323998 SCDC
- Bimatoprost 0.3 MG/ML Topical Solution [Latisse] 1041497 SBD
- Bimatoprost 0.3 MG/ML [Latisse] 833225 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Bimatoprost 0.3 MG/ML SCDC · 323998
Bimatoprost Topical Solution SCDF · 1041494
Bimatoprost Topical Product SCDG · 1161199

Brand-Name Concepts

Bimatoprost 0.3 MG/ML Topical Solution [Latisse] SBD · 1041497
Bimatoprost 0.3 MG/ML [Latisse] SBDC · 833225
Bimatoprost Topical Solution [Latisse] SBDF · 1041496
Latisse Topical Product SBDG · 1175655
Latisse BN · 831948

📦 FDA Products & Package NDCs

3 products · 7 package NDCs

7 package NDCs map to RxCUI 1041495 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00023-3616-05	1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) / 5 mL in 1 BO...	LATISSE	Allergan, Inc.	2009-01-26
00023-3616-70	1 BOTTLE, DROPPER in 1 CARTON (0023-3616-70) / 3 mL in 1 BO...	LATISSE	Allergan, Inc.	2009-01-26
00023-3616-71	1 BOTTLE, DROPPER in 1 CARTON (0023-3616-71) / 3 mL in 1 BO...	LATISSE	Allergan, Inc.	2009-01-26
00781-6206-75	1 BOTTLE, WITH APPLICATOR in 1 CARTON (0781-6206-75) / 5 mL...	Bimatoprost	Sandoz Inc	2016-12-06
00781-6206-93	1 BOTTLE, WITH APPLICATOR in 1 CARTON (0781-6206-93) / 3 mL...	Bimatoprost	Sandoz Inc	2016-12-06
62332-0511-03	1 BOTTLE in 1 CARTON (62332-511-03) / 3 mL in 1 BOTTLE	bimatoprost	Alembic Pharmaceuticals Inc.	2020-03-20
62332-0511-05	1 BOTTLE in 1 CARTON (62332-511-05) / 5 mL in 1 BOTTLE	bimatoprost	Alembic Pharmaceuticals Inc.	2020-01-21

Observed labelers: Allergan, Inc. (3) · Alembic Pharmaceuticals Inc. (2) · Sandoz Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$27.0501

Range $21.9732–$41.0015 · middle 50% $23.2424–$30.3361 · 6 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.